Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Phase 2/3 Recruiting 300 enrolled Exciva GmbH

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's Disease dementia.

Timeline

Start: 2026-02-02
Primary completion: 2029-01
Completion: 2029-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	EXV-801	Unknown	—	—
Subject	EXV-802	Unknown	—	—

Indications

No indication recorded.